Login / Signup

A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability.

Daryl EfronJeremy L FreemanNoel CranswickJonathan M PayneMelissa MulraneyChidambaram PrakashKatherine J LeeKaitlyn TaylorKatrina Williams
Published in: British journal of clinical pharmacology (2020)
The findings suggest that the study protocol is feasible and acceptable to patients with ID and SBP and their families.
Keyphrases
  • intellectual disability
  • study protocol
  • double blind
  • randomized controlled trial
  • autism spectrum disorder
  • open label
  • clinical trial
  • mental health
  • placebo controlled
  • early onset
  • drug induced